يعرض 1 - 10 نتائج من 54 نتيجة بحث عن '"Gobbi, Angela"', وقت الاستعلام: 1.22s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Low-Dose Oral Ethinylestradiol With Concomitant Low-Dose Acetylsalicylic Acid for Advanced Castrate-Resistant Prostate Cancer

    المؤلفون: ROVIELLO, GIANDOMENICO, Zanotti, Laura, Gobbi, Angela, Dester, Martina, GENERALI, DANIELE, Pacifico, Chiara, Cappelletti, Maria Rosa, Bonetta, Alberto

    المساهمون: Roviello, Giandomenico, Zanotti, Laura, Gobbi, Angela, Dester, Martina, Generali, Daniele, Pacifico, Chiara, Cappelletti, Maria Rosa, Bonetta, Alberto

    مصطلحات موضوعية: Castration-resistant prostate cancer, Estrogen, Hormonal therapy, Oncology, Urology, Ethinylestradiol

    وصف الملف: STAMPA

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/27692697; info:eu-repo/semantics/altIdentifier/wos/WOS:000405762100006; volume:15; issue:3; firstpage:371; lastpage:375; numberofpages:5; journal:CLINICAL GENITOURINARY CANCER; http://hdl.handle.net/11368/2903803Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84999635771; http://www.sciencedirect.com/science/article/pii/S1558767316302580Test

    الإتاحة: https://doi.org/10.1016/j.clgc.2016.08.024Test
    http://hdl.handle.net/11368/2903803Test
    http://www.sciencedirect.com/science/article/pii/S1558767316302580Test

    View record in BASE

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Targeting the androgenic pathway in elderly patients with castration-resistant prostate cancer: A meta-analysis of randomized trials

    المؤلفون: ROVIELLO, GIANDOMENICO, GENERALI, DANIELE, Cappelletti, Maria Rosa, Zanotti, Laura, Gobbi, Angela, Senti, Chiara, Bottini, Alberto, Ravelli, Andrea, Bonetta, Alberto, Paganini, Giovanni

    المساهمون: Roviello, Giandomenico, Cappelletti, Maria Rosa, Zanotti, Laura, Gobbi, Angela, Senti, Chiara, Bottini, Alberto, Ravelli, Andrea, Bonetta, Alberto, Paganini, Giovanni, Generali, Daniele

    مصطلحات موضوعية: Abiraterone acetate, Elderly, Enzalutamide, Orteronel, Prostate cancer, Aged, Androgen Antagonist, Human, Male, Prostatic Neoplasms, Castration-Resistant, Treatment Outcome, Randomized Controlled Trials as Topic, Medicine (all)

    وصف الملف: ELETTRONICO

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/27787354; info:eu-repo/semantics/altIdentifier/wos/WOS:000387272700002; volume:95; issue:43; firstpage:-; lastpage:-; numberofpages:6; journal:MEDICINE; http://hdl.handle.net/11368/2903817Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84995955686; http://journals.lww.com/md-journal/pages/articleviewer.aspx?year=2016&issue=10250&article=00002&type=abstractTest

    الإتاحة: https://doi.org/10.1097/MD.0000000000004636Test
    http://hdl.handle.net/11368/2903817Test
    http://journals.lww.com/md-journal/pages/articleviewer.aspx?year=2016&issue=10250&article=00002&type=abstractTest

    View record in BASE

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Apatinib for the treatment of gastric cancer

    المؤلفون: ROVIELLO, GIANDOMENICO, GENERALI, DANIELE, Ravelli, Andrea, Fiaschi, Anna Ida, Cappelletti, Maria Rosa, Gobbi, Angela, Senti, Chiara, Zanotti, Laura, Polom, Karol, Reynolds, Andrew R., Fox, Stephen B.

    المساهمون: Roviello, Giandomenico, Ravelli, Andrea, Fiaschi, Anna Ida, Cappelletti, Maria Rosa, Gobbi, Angela, Senti, Chiara, Zanotti, Laura, Polom, Karol, Reynolds, Andrew R., Fox, Stephen B., Generali, Daniele

    مصطلحات موضوعية: angiogenesi, apatinib, chemotherapy, Gastric cancer, VEGFR2, Hepatology, Gastroenterology

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/27376400; info:eu-repo/semantics/altIdentifier/wos/WOS:000381319000003; volume:10; issue:8; firstpage:887; lastpage:892; numberofpages:6; journal:EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY; http://hdl.handle.net/11368/2903752Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84978488642

    الإتاحة: https://doi.org/10.1080/17474124.2016.1209407Test
    http://hdl.handle.net/11368/2903752Test

    View record in BASE

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Is still there a role for IL-2 for solid tumors other than melanoma or renal cancer?

    المؤلفون: ROVIELLO, GIANDOMENICO, GUGLIELMI, ALESSANDRA, GENERALI, DANIELE, Zanotti, Laura, Correale, Pierpaolo, Gobbi, Angela, Wigfield, Simon, Pacifico, Chiara

    المساهمون: Roviello, Giandomenico, Zanotti, Laura, Correale, Pierpaolo, Gobbi, Angela, Wigfield, Simon, Guglielmi, Alessandra, Pacifico, Chiara, Generali, Daniele

    مصطلحات موضوعية: chemotherapy, interleukin-2, solid tumor, Immunology and Allergy, Immunology, Oncology

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/28000528; info:eu-repo/semantics/altIdentifier/wos/WOS:000397497200005; volume:9; issue:1; firstpage:25; lastpage:32; numberofpages:8; journal:IMMUNOTHERAPY; http://hdl.handle.net/11368/2903592Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85007174600

    الإتاحة: https://doi.org/10.2217/imt-2016-0107Test
    http://hdl.handle.net/11368/2903592Test

    View record in BASE

    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    CDK4/6 inhibitors in HER2-positive breast cancer

    المؤلفون: Corona, Silvia Paola, Cretella, Daniele, Cappelletti, Maria Rosa, Zanotti, Laura, Dester, Martina, Gobbi, Angela, Petronini, Pier Giorgio, Ravelli, Angelo, GENERALI, DANIELE

    المساهمون: Corona, Silvia Paola, Ravelli, Angelo, Cretella, Daniele, Cappelletti, Maria Rosa, Zanotti, Laura, Dester, Martina, Gobbi, Angela, Petronini, Pier Giorgio, Generali, Daniele

    مصطلحات موضوعية: Abemaciclib, Advanced breast cancer, Breast cancer, Cyclin-dependent kinases (CDK), HER2 positive BC, Palbociclib, Ribociclib

    وصف الملف: STAMPA

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/28325261; info:eu-repo/semantics/altIdentifier/wos/WOS:000398757300019; volume:112; firstpage:208; lastpage:214; numberofpages:7; journal:CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY; http://hdl.handle.net/11368/2903558Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85015643653; http://www.sciencedirect.com/science/article/pii/S104084281630333XTest

    الإتاحة: https://doi.org/10.1016/j.critrevonc.2017.02.022Test
    http://hdl.handle.net/11368/2903558Test
    http://www.sciencedirect.com/science/article/pii/S104084281630333XTest

    View record in BASE

    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    Are EGFR tyrosine kinase inhibitors effective in elderly patients with EGFR-mutated non-small cell lung cancer?

    المؤلفون: ROVIELLO, GIANDOMENICO, Zanotti, Laura, Cappelletti, Maria Rosa, Gobbi, Angela, Dester, Martina, Paganini, Giovanni, Pacifico, Chiara, GENERALI, DANIELE, Roudi, Raheleh

    المساهمون: Roviello, Giandomenico, Zanotti, Laura, Cappelletti, Maria Rosa, Gobbi, Angela, Dester, Martina, Paganini, Giovanni, Pacifico, Chiara, Generali, Daniele, Roudi, Raheleh

    مصطلحات موضوعية: Afatinib, EGFR, Elderly, Erlotinib, Gefitinib

    وصف الملف: ELETTRONICO

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/28391544; info:eu-repo/semantics/altIdentifier/wos/WOS:000424231400002; firstpage:"-"; lastpage:"-"; numberofpages:6; journal:CLINICAL AND EXPERIMENTAL MEDICINE; http://hdl.handle.net/11368/2903512Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85017109497; https://link.springer.com/article/10.1007%2Fs10238-017-0460-7Test

    الإتاحة: https://doi.org/10.1007/s10238-017-0460-7Test
    http://hdl.handle.net/11368/2903512Test

    View record in BASE

    أضف إلى المفضلة
  7. 7
    دورية أكاديمية
    New molecular therapies in patients with advanced Hepatocellular Cancer in second line of treatment: Is a real defeat?: Results from a literature based meta-analysis of randomized trials

    المؤلفون: ROVIELLO, GIANDOMENICO, GENERALI, DANIELE, Zanotti, Laura, Cappelletti, Maria Rosa, Gobbi, Angela, Borsella, Giulia, Pacifico, Chiara, Multari, Andrea Giovanni

    المساهمون: Roviello, Giandomenico, Zanotti, Laura, Cappelletti, Maria Rosa, Gobbi, Angela, Borsella, Giulia, Pacifico, Chiara, Multari, Andrea Giovanni, Generali, Daniele

    مصطلحات موضوعية: Everolimu, Hepatocellular cancer, Ramucirumab, Second line, Target therapie, Animal, Human, Liver Neoplasm, Molecular Targeted Therapy, Randomized Controlled Trials as Topic, Hematology, Oncology, Geriatrics and Gerontology

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/27931841; info:eu-repo/semantics/altIdentifier/wos/WOS:000390719700007; volume:108; firstpage:62; lastpage:68; numberofpages:7; journal:CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY; http://hdl.handle.net/11368/2903813Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85006390493; http://www.sciencedirect.com/science/article/pii/S1040842816302815Test

    الإتاحة: https://doi.org/10.1016/j.critrevonc.2016.10.015Test
    http://hdl.handle.net/11368/2903813Test
    http://www.sciencedirect.com/science/article/pii/S1040842816302815Test

    View record in BASE

    أضف إلى المفضلة
  8. 8
    دورية أكاديمية
    No Advantage in Survival With Targeted Therapies as Maintenance in Patients With Limited and Extensive-Stage Small Cell Lung Cancer: A Literature-Based Meta-Analysis of Randomized Trials

    المؤلفون: ROVIELLO, GIANDOMENICO, GENERALI, DANIELE, Zanotti, Laura, Cappelletti, Maria Rosa, Gobbi, Angela, Senti, Chiara, Bottini, Alberto

    المساهمون: Roviello, Giandomenico, Zanotti, Laura, Cappelletti, Maria Rosa, Gobbi, Angela, Senti, Chiara, Bottini, Alberto, Generali, Daniele

    مصطلحات موضوعية: Bevacizumab, Maintenance, SCLC, Target therapy, Thalidomide, Oncology, Pulmonary and Respiratory Medicine, Cancer Research

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/27346522; info:eu-repo/semantics/altIdentifier/wos/WOS:000386317200003; volume:17; issue:5; firstpage:334; lastpage:340; numberofpages:7; journal:CLINICAL LUNG CANCER; http://hdl.handle.net/11368/2903784Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84995676823; http://www.sciencedirect.com/science/article/pii/S1525730416301139Test

    الإتاحة: https://doi.org/10.1016/j.cllc.2016.05.008Test
    http://hdl.handle.net/11368/2903784Test
    http://www.sciencedirect.com/science/article/pii/S1525730416301139Test

    View record in BASE

    أضف إلى المفضلة
  9. 9
    دورية أكاديمية
    A Phase Ib Open-Label Study to Assess the Safety and Tolerability of Everolimus in Combination with Eribulin in Triple-Negative Breast Cancers

    المؤلفون: ROVIELLO, GIANDOMENICO, GENERALI, DANIELE, Milani, Manuela, Gobbi, Angela, Cappelletti, Maria Rosa, Zanotti, Laura, Senti, Chiara, Bottini, Alberto, Strina, Carla, Sigala, Sandra

    المساهمون: Roviello, Giandomenico, Milani, Manuela, Gobbi, Angela, Cappelletti, Maria Rosa, Zanotti, Laura, Senti, Chiara, Bottini, Alberto, Strina, Carla, Sigala, Sandra, Generali, Daniele

    مصطلحات موضوعية: Basal like, Chemotherapy, Combination treatment, mtor inhibitor, Taxane, Cancer Research, Oncology

    وصف الملف: ELETTRONICO

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/26943987; info:eu-repo/semantics/altIdentifier/wos/WOS:000377401900006; volume:16; issue:3; firstpage:e57; lastpage:e59; journal:CLINICAL BREAST CANCER; http://hdl.handle.net/11368/2903748Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84961158634; http://www.sciencedirect.com/science/article/pii/S1526820916300325Test

    الإتاحة: https://doi.org/10.1016/j.clbc.2016.02.012Test
    http://hdl.handle.net/11368/2903748Test
    http://www.sciencedirect.com/science/article/pii/S1526820916300325Test

    View record in BASE

    أضف إلى المفضلة
  10. 10
    دورية أكاديمية
    A Phase II study of olaparib in breast cancer patients: Biological evaluation from a 'window of opportunity' trial

    المؤلفون: ROVIELLO, GIANDOMENICO, GENERALI, DANIELE, Milani, Manuela, Gobbi, Angela, Dester, Martina, Cappelletti, Maria Rosa, Allevi, Giovanni, Aguggini, Sergio, Ravelli, Andrea, Gussago, Francesca, Cocconi, Alessandra, Zanotti, Laura, Senti, Chiara, Strina, Carla, Bottini, Alberto

    المساهمون: Roviello, Giandomenico, Milani, Manuela, Gobbi, Angela, Dester, Martina, Cappelletti, Maria Rosa, Allevi, Giovanni, Aguggini, Sergio, Ravelli, Andrea, Gussago, Francesca, Cocconi, Alessandra, Zanotti, Laura, Senti, Chiara, Strina, Carla, Bottini, Alberto, Generali, Daniele

    مصطلحات موضوعية: BRCA, Olaparib, Triple-negative breast cancer, Antineoplastic Agent, Breast Neoplasm, Drug Administration Schedule, Female, Human, Molecular Targeted Therapy, Neoplasm Staging, Phthalazine, Piperazine, Poly(ADP-ribose) Polymerase Inhibitor, Treatment Outcome, Triple Negative Breast Neoplasm, Oncology, Cancer Research

    وصف الملف: STAMPA

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/27324108; info:eu-repo/semantics/altIdentifier/wos/WOS:000383504900004; volume:12; issue:19; firstpage:2189; lastpage:2193; numberofpages:5; journal:FUTURE ONCOLOGY; http://hdl.handle.net/11368/2903590Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84988663650

    الإتاحة: https://doi.org/10.2217/fon-2016-0116Test
    http://hdl.handle.net/11368/2903590Test

    View record in BASE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث